Tag Archives: gp100
Immunocore – T cell receptor-based drugs
Immunocore is a clinical-stage biotech company focused on the development of novel T cell receptor-based drugs to treat cancers and viral diseases. Immunocore is the world-leader in engineering T Cell Receptors (TCRs) and link them to an antibody fragment (scFv). Its first product candidate, IMCgp100, entered clinical trials in patients with metastatic melanoma.